|Bid||6.49 x 1400|
|Ask||6.55 x 1000|
|Day's Range||6.33 - 6.53|
|52 Week Range||3.49 - 10.39|
|Beta (5Y Monthly)||2.47|
|PE Ratio (TTM)||N/A|
|Earnings Date||Oct 31, 2022 - Nov 04, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||12.00|
Subscribe to Yahoo Finance Plus to view Fair Value for APEN
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
Apollo Endosurgery, Inc. (APEN) delivered earnings and revenue surprises of -23.81% and 7.62%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced financial results for the second quarter ended June 30, 2022 and recent corporate highlights.